Quantitative structure–activity relationship (QSAR) and molecular docking of xanthone derivatives as anti-tuberculosis agents
Open Access
- 16 November 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
- Vol. 21, 100203
- https://doi.org/10.1016/j.jctube.2020.100203
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Exploring the Potential Inhibition of Candidate Drug Molecules for Clinical Investigation Based on their Docking or Crystallographic Analyses against M. tuberculosis Enzyme TargetsCurrent Topics in Medicinal Chemistry, 2020
- Mycobacterial tuberculosis Enzyme Targets and their InhibitorsCurrent Topics in Medicinal Chemistry, 2019
- Theoretical modeling and molecular docking simulation for investigating and evaluating some active compounds as potent anti-tubercular agents against MTB CYP121 receptorFuture Journal of Pharmaceutical Sciences, 2018
- Xanthone as Antimalarial: QSAR Analysis, Synthesis, Molecular Docking and In-vitro Antimalarial EvaluationOriental Journal of Chemistry, 2017
- QSAR Study on Arylthioquinoline Derivatives as Anti-tubercular AgentsPharmacology, Toxicology and Biomedical Reports, 2015
- Synthesis of xanthone derivatives with extended π-systems as α-glucosidase inhibitors: Insight into the probable binding modeBioorganic & Medicinal Chemistry, 2007
- Fighting tuberculosis: An old disease with new challengesMedicinal Research Reviews, 2005
- QSAR modeling of the MAO inhibitory activity of xanthones derivativesBioorganic & Medicinal Chemistry Letters, 2004
- Development of QSAR Models To Predict and Interpret the Biological Activity of Artemisinin AnaloguesJournal of Chemical Information and Computer Sciences, 2004
- NMR studies of N-(benzimidazol-2-yl)pyridinium derivatives: QSAR with the anti-leishmanial activity and their carbon-13 NMR chemical shiftsEuropean Journal of Medicinal Chemistry, 1991